| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1007/S00787-006-0563-2 |
| P698 | PubMed publication ID | 16932856 |
| P2093 | author name string | Roberto Canitano | |
| P2860 | cites work | Autistic regression and Landau–Kleffner syndrome: progress or confusion? | Q22251420 |
| The genetics of autism | Q28259677 | ||
| Serotonin in autism and pediatric epilepsies | Q30958476 | ||
| Epilepsy and epileptiform EEG: association with autism and language disorders | Q33927352 | ||
| The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep | Q33966120 | ||
| Epilepsy in autism | Q33966993 | ||
| Treatment of aggression in children and adolescents with autism and conduct disorder. | Q34187922 | ||
| Antiepileptic drugs: affective use in autism spectrum disorders. | Q34392445 | ||
| Serotonin and brain development: role in human developmental diseases | Q34467013 | ||
| Acquired epileptiform aphasia: a dimensional view of Landau-Kleffner syndrome and the relation to regressive autistic spectrum disorders | Q35132337 | ||
| Epidemiological surveys of autism and other pervasive developmental disorders: an update | Q35213382 | ||
| Cognitive impairment during epileptiform discharges: is it ever justifiable to treat the EEG? | Q35592627 | ||
| Behavioral aspects of pediatric epilepsy syndromes | Q35630222 | ||
| Understanding co-morbidities affecting children with epilepsy | Q35684997 | ||
| Neuropsychiatric problems in tuberous sclerosis complex | Q35783807 | ||
| Sleep disorders, epilepsy, and autism | Q35884873 | ||
| Neuroepileptic correlates of autistic symptomatology in tuberous sclerosis | Q35884877 | ||
| Epileptic encephalopathies and their relationship to developmental disorders: do spikes cause autism? | Q35884881 | ||
| AEDs and psychotropic drugs in children with autism and epilepsy | Q35884885 | ||
| Rett syndrome: of girls and mice--lessons for regression in autism | Q35884900 | ||
| Seizures and epilepsy among children with language regression and autistic spectrum disorders | Q35939602 | ||
| Electroencephalography findings in autism: similarities and differences from Landau-Kleffner syndrome | Q35969713 | ||
| Acquired epileptiform aphasia in children (Landau-Kleffner syndrome). | Q37381831 | ||
| Language regression in childhood | Q40713637 | ||
| Significance and management of transitory cognitive impairment due to subclinical EEG discharges in children | Q40828641 | ||
| Autistic regression and disintegrative disorder: how important the role of epilepsy? | Q41677426 | ||
| An open trial of divalproex sodium in autism spectrum disorders. | Q42656234 | ||
| Seizure disorders in autism | Q43436169 | ||
| Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial | Q43671991 | ||
| Prospective preliminary analysis of the development of autism and epilepsy in children with infantile spasms | Q44430244 | ||
| Clomipramine in autism: preliminary evidence of efficacy | Q45018488 | ||
| The yield of laboratory investigations in children with infantile autism | Q45122885 | ||
| Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders | Q48121862 | ||
| Autistic regression with rolandic spikes. | Q48130832 | ||
| Outcome of multiple subpial transections for autistic epileptiform regression | Q48148622 | ||
| Features of autism in Rett syndrome and severe mental retardation | Q48205809 | ||
| Epilepsy in disintegrative psychosis and infantile autism: a long-term validation study | Q48265376 | ||
| Autism and autistic epileptiform regression with occipital spikes | Q48414816 | ||
| Not EEG abnormalities but epilepsy is associated with autistic regression and mental functioning in childhood autism | Q48580984 | ||
| Frequency of EEG abnormalities in age-matched siblings of autistic children with abnormal sleep EEG patterns | Q48594291 | ||
| Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex | Q48599433 | ||
| Sleep patterns in autistic children | Q48759177 | ||
| Regression in pervasive developmental disorders: seizures and epileptiform electroencephalogram correlates | Q50302632 | ||
| Clinical and neurophysiological aspects of epilepsy in subjects with autism and mental retardation. | Q50303696 | ||
| EEG features and epilepsy in patients with autism | Q50303761 | ||
| Epilepsy in Children With Autistic Spectrum Disorder | Q50304836 | ||
| Autistic and dysphasic children. II: Epilepsy | Q50305911 | ||
| The treatment of epilepsy in autism | Q50306293 | ||
| Epilepsy, electroencephalographic abnormalities, and regression in children with autism | Q50306548 | ||
| EEG and seizures in autistic children and adolescents: further findings with therapeutic implications | Q50306823 | ||
| Epilepsy is not a prominent feature of primary autism. | Q50307678 | ||
| Epilepsy in autism and autisticlike conditions. A population-based study | Q50307728 | ||
| The incidence of seizures among children with autistic symptoms | Q50309478 | ||
| Commentary: the treatment of seizure disorders and EEG abnormalities in children with autistic spectrum disorders: are we getting ahead of ourselves? | Q50312114 | ||
| Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders | Q50312124 | ||
| Epilepsy in adolescents and young adults with autistic disorder | Q50313117 | ||
| Magnetoencephalographic patterns of epileptiform activity in children with regressive autism spectrum disorders | Q50313667 | ||
| Autism spectrum disorders in children with active epilepsy and learning disability: comorbidity, pre- and perinatal background, and seizure characteristics | Q50343534 | ||
| P433 | issue | 1 | |
| P921 | main subject | autism | Q38404 |
| autism spectrum disorder | Q1436063 | ||
| P304 | page(s) | 61-66 | |
| P577 | publication date | 2006-08-24 | |
| P1433 | published in | European Child & Adolescent Psychiatry | Q15750166 |
| P1476 | title | Epilepsy in autism spectrum disorders | |
| P478 | volume | 16 |
| Q37663290 | 2-Methyl-6-(phenylethynyl) pyridine (MPEP) reverses maze learning and PSD-95 deficits in Fmr1 knock-out mice |
| Q33690844 | A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders |
| Q39949065 | Abnormal cell patterning at the cortical gray–white matter boundary in autism spectrum disorders |
| Q37300512 | Acetaminophen Use for Fever in Children Associated with Autism Spectrum Disorder |
| Q35996972 | An assessment of sex bias in neurodevelopmental disorders |
| Q33791880 | An inside job: how endosomal Na(+)/H(+) exchangers link to autism and neurological disease |
| Q37705088 | Analysis of Copy Number Variations in Patients with Autism Using Cytogenetic and MLPA Techniques: Report of 16p13.1p13.3 and 10q26.3 Duplications |
| Q41933122 | Autism and Epilepsy: Exploring the Relationship Using Experimental Models |
| Q50211164 | Autism spectrum disorder phenotype and intellectual disability in females with epilepsy and PCDH-19 mutations |
| Q57046875 | Autism-linked CHD gene expression patterns during development predict multi-organ disease phenotypes |
| Q46389861 | Autistic disorder in Nigeria: profile and challenges to management |
| Q21092167 | Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review |
| Q46056451 | Brief Report: Factors Associated with Emergency Department Visits for Epilepsy Among Children with Autism Spectrum Disorder. |
| Q50301218 | Bumetanide for autism: more eye contact, less amygdala activation |
| Q48652367 | Childhood autism spectrum disorders with and without epilepsy: clinical implications |
| Q50302758 | Childhood disintegrative disorder: distinction from autistic disorder and predictors of outcome |
| Q28308288 | Chromosome 8p as a potential hub for developmental neuropsychiatric disorders: implications for schizophrenia, autism and cancer |
| Q34826206 | Clinical characteristics of children with autism spectrum disorder and co-occurring epilepsy |
| Q35863984 | Coloured filters enhance the visual perception of social cues in children with autism spectrum disorders |
| Q26269924 | Common circuit defect of excitatory-inhibitory balance in mouse models of autism |
| Q34368185 | Comparative RNA editing in autistic and neurotypical cerebella. |
| Q38918713 | Compliance with cochlear implantation in children subsequently diagnosed with autism spectrum disorder. |
| Q47962206 | Copy Number Variants in Patients with Autism and Additional Clinical Features: Report of VIPR2 Duplication and a Novel Microduplication Syndrome. |
| Q30586961 | Disruption of the non-canonical Wnt gene PRICKLE2 leads to autism-like behaviors with evidence for hippocampal synaptic dysfunction |
| Q34249436 | Does epilepsy in multiplex autism pedigrees define a different subgroup in terms of clinical characteristics and genetic risk? |
| Q48020417 | Dysregulation of Cortical Neuron DNA Methylation Profile in Autism Spectrum Disorder. |
| Q35180614 | Early-life seizures result in deficits in social behavior and learning |
| Q92344057 | Early-life status epilepticus induces long-term deficits in anxiety and spatial learning in mice |
| Q90390720 | Environmental enrichment alleviates cognitive and behavioral impairments in EL mice |
| Q37706525 | Epidemiology and management of insomnia in children with autistic spectrum disorders |
| Q50302883 | Epilepsy and autism: a complex issue |
| Q50313398 | Epilepsy and other central nervous system diseases in atypical autism: a case control study |
| Q37826764 | Epilepsy as a spectrum disorder: Implications from novel clinical and basic neuroscience |
| Q44230599 | Epilepsy in individuals with a history of Asperger's syndrome: a Danish nationwide register-based cohort study |
| Q37319772 | Expression of GABA(B) receptors is altered in brains of subjects with autism |
| Q44849904 | Family report of ASD concomitant with depression or anxiety among US children |
| Q48956956 | Fetal domoic acid exposure affects lateral amygdala neurons, diminishes social investigation and alters sensory-motor gating. |
| Q35014198 | Frontier of epilepsy research - mTOR signaling pathway |
| Q89609712 | GABAergic interneurons in epilepsy: More than a simple change in inhibition |
| Q34568690 | GABAergic/glutamatergic imbalance relative to excessive neuroinflammation in autism spectrum disorders |
| Q64240282 | Genetics and epigenetics of autism spectrum disorder-current evidence in the field |
| Q58797492 | Genomics in neurodevelopmental disorders: an avenue to personalized medicine |
| Q50313306 | Ghrelin as a promising therapeutic target for co-occurring autism and epilepsy |
| Q24655308 | Identifying autism loci and genes by tracing recent shared ancestry |
| Q36985727 | Impairment of fragile X mental retardation protein-metabotropic glutamate receptor 5 signaling and its downstream cognates ras-related C3 botulinum toxin substrate 1, amyloid beta A4 precursor protein, striatal-enriched protein tyrosine phosphatase, |
| Q92358872 | Increased Ca2+ signaling in NRXN1α +/- neurons derived from ASD induced pluripotent stem cells |
| Q38543727 | Is birth a critical period in the pathogenesis of autism spectrum disorders? |
| Q37469694 | Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome |
| Q47686943 | Judging the Intensity of Emotional Expression in Faces: the Effects of Colored Tints on Individuals With Autism Spectrum Disorder. |
| Q34014157 | Ketogenic diets and pain |
| Q50344457 | Long-Term Outcomes in Children Diagnosed with Autism Spectrum Disorders in India |
| Q36391150 | Matrix Metalloproteinase-9 Regulates Neuronal Circuit Development and Excitability |
| Q50313076 | May lovastatin target both autism and epilepsy? A novel hypothesized treatment |
| Q38272133 | Medical conditions in autism spectrum disorders |
| Q24630557 | Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis |
| Q29616196 | Neocortical excitation/inhibition balance in information processing and social dysfunction |
| Q64236596 | Neuroactive Steroids Reverse Tonic Inhibitory Deficits in Fragile X Syndrome Mouse Model |
| Q34760483 | Neurons in the fusiform gyrus are fewer and smaller in autism |
| Q39159673 | Outcome of childhood-onset epilepsy from adolescence to adulthood: Transition issues |
| Q54962793 | PV Interneurons: Critical Regulators of E/I Balance for Prefrontal Cortex-Dependent Behavior and Psychiatric Disorders. |
| Q41922993 | Perinatal Immune Activation Produces Persistent Sleep Alterations and Epileptiform Activity in Male Mice |
| Q30569745 | Pharmacological inhibition of mTORC1 suppresses anatomical, cellular, and behavioral abnormalities in neural-specific Pten knock-out mice |
| Q48032264 | Phenotypic differences in individuals with autism spectrum disorder born preterm and at term gestation |
| Q37663243 | Prevalence and comorbidities of autism among children referred to the outpatient clinics for neurodevelopmental disorders |
| Q37804959 | Psychopharmacology in autism: An update |
| Q45298736 | Psychotropic Medication Use among Insured Children with Autism Spectrum Disorder |
| Q36442658 | RYR2, PTDSS1 and AREG genes are implicated in a Lebanese population-based study of copy number variation in autism. |
| Q26744368 | Recent Advances in Autism Spectrum Disorders: Applications of Whole Exome Sequencing Technology |
| Q21342782 | Recent advances in the pathogenesis of syndromic autisms |
| Q50127363 | Reduced Glutamate Release in Adult BTBR Mouse Model of Autism Spectrum Disorder |
| Q36125646 | Reduced perceptual exclusivity during object and grating rivalry in autism |
| Q36800845 | Resting-state oscillatory activity in autism spectrum disorders. |
| Q30235312 | Role of Genetics in the Etiology of Autistic Spectrum Disorder: Towards a Hierarchical Diagnostic Strategy |
| Q34209828 | SLC9A9 mutations, gene expression, and protein-protein interactions in rat models of attention-deficit/hyperactivity disorder |
| Q47677908 | Sensory perception in autism |
| Q39413658 | Statins and the Brain: More than Lipid Lowering Agents? |
| Q37582801 | Syndromic autism: causes and pathogenetic pathways |
| Q34329016 | Systematic genotype-phenotype analysis of autism susceptibility loci implicates additional symptoms to co-occur with autism |
| Q46624322 | Temporal lobe epilepsy and social behavior: an animal model for autism? |
| Q54976489 | The History of Comorbidity in Autism Spectrum Disorders (ASD) |
| Q26766054 | The PI3K signaling pathway as a pharmacological target in Autism related disorders and Schizophrenia. |
| Q37728626 | The association between epilepsy and autism symptoms and maladaptive behaviors in children with autism spectrum disorder |
| Q37045350 | The effect of epilepsy on autistic symptom severity assessed by the social responsiveness scale in children with autism spectrum disorder |
| Q50302277 | The effect of seizure disorder on symptom presentation in atypically developing children and children with autism spectrum disorders based on the BDI-2 |
| Q37937459 | The role of GABAergic system in neurodevelopmental disorders: a focus on autism and epilepsy |
| Q93013709 | Transcriptional Regulation of Channelopathies in Genetic and Acquired Epilepsies |
| Q42863461 | Transplantation of GABAergic cell line as a novel hypothesized treatment for autism |
| Q43538904 | Up-regulation of Ras/Raf/ERK1/2 signaling impairs cultured neuronal cell migration, neurogenesis, synapse formation, and dendritic spine development |
| Q42361497 | What California sea lions exposed to domoic acid might teach us about autism: lessons for predictive and preventive medicine |
| Q22252699 | What’s new in autism? |
Search more.